
Stock Earnings
Understanding the Risks of Investing in Alx Oncology Holdings Inc (ALXO)
Alx Oncology Holdings Inc’s recent filing unveils that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0
Alx Oncology Holdings Inc’s recent filing unveils that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0
Alx Oncology Holdings Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0 on
Alx Oncology Holdings Inc’s recently made public that its CHIEF EXECUTIVE OFFICER Lettmann Jason acquired Company’s shares for reported $76892.0
Alx Oncology Holdings Inc’s filing revealed that its Chief Financial Officer Shantharam Harish acquired Company’s shares for reported $58402.0 on
Alx Oncology Holdings Inc’s recently made public that its Chief Financial Officer Shantharam Harish acquired Company’s shares for reported $58402.0